{
    "nct_id": "NCT03822494",
    "official_title": "CyberKnife Dose Escalation for Unfavorable and High-risk Prostate Cancer",
    "inclusion_criteria": "* Histologically confirmed adenocarcinoma of the prostate diagnosed within 360 days of enrollment.\n* Prostate Specific Antigen (PSA) documented within 90 days prior to registration.\n* Clinical staging completed within 90 days of registration.\n* No Nodal or Distant Metastases documented on CT or MRI of the pelvis and bone scan.\n* Unfavorable Risk Prostate Carcinoma as Described is documented.\n* No prior pelvic radiotherapy.\n* No prior Trans-urethral resection of the prostate (TURP).\n* Prostate volume < 100 cc\n* American Urologic Association (AUA) score < 20\n* No recent (within 5 years) or concurrent cancers other than non-melanoma skin cancers.\n* Patient must have no medical or psychiatric illnesses that would interfere with treatment or follow-up.\n* No implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and treatment delivery is allowed.\n* Candidate for rectal spacer placement\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Other cancer diagnosis other than non-melanoma skin cancer with 5 years\n* Prostate size greater than 100cc\n* AUA greater than 20\n* Implanted hardware impacting imaging\n* Metastatic prostate cancer\n* Contraindication to hormone therapy",
    "miscellaneous_criteria": ""
}